Profile data is unavailable for this security.
About the company
TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. is a China-based company principally engaged in the production and distribution of pharmaceuticals. The Company operates its businesses through the distribution of proprietary drug products, as well as the processing of pharmaceuticals and others. The Company conducts its businesses primarily in South China, North China, East China, Central China and overseas markets.
- Revenue in CNY (TTM)2.94bn
- Net income in CNY737.44m
- Incorporated1999
- Employees601.00
- LocationTibet Rhodiola Pharmaceutical Holding CoNo. 19, Beijing Middle RoadLASA 850000ChinaCHN
- Phone+86 2 886653915
- Fax+86 2 886660740
- Websitehttp://www.xzyy.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KPC Pharmaceuticals Inc | 7.55bn | 446.07m | 11.65bn | 5.05k | 25.98 | 2.11 | -- | 1.54 | 0.5924 | 0.5924 | 10.03 | 7.31 | 0.7819 | 2.75 | 2.56 | 1,494,697.00 | 4.64 | 5.42 | 7.75 | 9.13 | 40.84 | 43.68 | 5.94 | 5.70 | 1.51 | -- | 0.172 | 35.75 | -6.99 | 1.64 | 16.05 | 5.79 | -21.33 | 14.87 |
| Liaoning Chengda Biotechnology Co Ltd | 1.72bn | 332.10m | 11.66bn | 1.73k | 34.86 | 1.22 | -- | 6.79 | 0.8032 | 0.8032 | 4.16 | 22.93 | 0.1702 | 0.763 | 1.43 | 991,973.80 | 3.29 | 10.63 | 3.41 | 11.01 | 80.53 | 85.74 | 19.33 | 39.56 | 17.44 | -- | 0.0018 | 31.53 | -3.58 | 4.71 | -34.75 | -5.56 | 39.78 | -- |
| Chongqing Genrix Biophrmctcl Co Ltd | 13.56m | -779.42m | 11.69bn | 547.00 | -- | 4.97 | -- | 862.33 | -2.13 | -2.13 | 0.037 | 6.42 | 0.0039 | 0.1009 | 1.37 | 24,790.27 | -22.22 | -- | -23.06 | -- | 55.87 | -- | -5,747.82 | -- | 18.62 | -- | 0.2454 | -- | 154.92 | -- | -39.03 | -- | -- | -- |
| Henan Lingrui Pharmaceutical Co., Ltd. | 3.56bn | 675.80m | 12.36bn | 2.53k | 18.16 | 4.27 | -- | 3.47 | 1.20 | 1.20 | 6.34 | 5.10 | 0.7489 | 2.24 | 10.18 | 1,408,620.00 | 14.20 | 10.68 | 23.52 | 16.56 | 72.35 | 74.42 | 18.96 | 14.92 | 0.9579 | -- | 0.0073 | 72.80 | 10.31 | 10.03 | 22.09 | 18.49 | -16.47 | 39.77 |
| Zhejiang CONBA Pharmaceutical Co., Ltd. | 6.46bn | 486.79m | 12.49bn | 8.41k | 25.42 | 1.88 | -- | 1.93 | 0.1912 | 0.1912 | 2.54 | 2.59 | 0.618 | 2.39 | 4.56 | 768,224.60 | 4.98 | 6.77 | 6.93 | 10.50 | 51.47 | 63.24 | 8.06 | 11.10 | 1.24 | -- | 0.0781 | 42.32 | 12.20 | -0.8267 | 65.20 | -6.21 | -11.64 | 5.92 |
| Tibet Rhodiola Pharmaceutical Holding Co | 2.94bn | 737.44m | 12.58bn | 601.00 | 15.14 | 3.47 | -- | 4.28 | 2.58 | 2.58 | 9.69 | 11.26 | 0.6264 | 1.54 | 6.79 | 4,894,779.00 | 15.80 | 12.44 | 20.83 | 15.71 | 93.36 | 90.51 | 25.22 | 20.43 | 3.44 | 7.74 | 0.1264 | 50.41 | 22.69 | 24.98 | 116.56 | 30.01 | -1.48 | 48.97 |
| BrightGene Bio-Medical Technology Co Ltd | 1.24bn | 188.08m | 12.69bn | 1.16k | 67.24 | 5.39 | -- | 10.22 | 0.4466 | 0.4466 | 2.96 | 5.57 | 0.2522 | 1.63 | 3.50 | 1,074,862.00 | 2.91 | 6.53 | 3.57 | 7.93 | 54.97 | 56.93 | 11.55 | 19.90 | 1.18 | 4.53 | 0.4841 | 29.31 | 15.94 | 23.68 | -15.51 | 22.56 | 29.13 | -- |
| Jiang Zhong Pharmaceutical Co Ltd | 4.22bn | 753.16m | 13.51bn | 4.01k | 17.90 | 3.63 | -- | 3.20 | 1.20 | 1.20 | 6.71 | 5.91 | 0.6828 | 3.58 | 15.12 | 1,052,061.00 | 13.36 | 10.82 | 20.72 | 15.08 | 63.72 | 65.02 | 19.56 | 18.17 | 0.8833 | -- | 0.0004 | 82.88 | 13.00 | 20.12 | 18.40 | 8.54 | 11.47 | 40.99 |
Data as of Sep 13 2024. Currency figures normalised to Tibet Rhodiola Pharmaceutical Holding Co's reporting currency: Chinese Yuan Renminbi CNY
2.62%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Essence Fund Co., Ltd.as of 30 Jun 2024 | 2.37m | 0.74% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2024 | 1.13m | 0.35% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 957.79k | 0.30% |
| The Vanguard Group, Inc.as of 02 Oct 2024 | 918.63k | 0.29% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 745.19k | 0.23% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 500.80k | 0.16% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 498.69k | 0.16% |
| Gfund Management Co., Ltd.as of 30 Jun 2024 | 481.69k | 0.15% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 457.96k | 0.14% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 396.89k | 0.12% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
